Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis

Immunogenetics

Volumn 51, Issue 3, 2000, Pages 201-205

  Allen, Michael H ^a   Wakelin, Sarah H ^a   Holloway, Doris ^a   Lisby, Steen ^b   Baadsgaard, Ole ^b   Barker, Jonathan N W N ^a   McFadden, John P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Genetics; Inflammation; PCR RFLP; Skin; TNFA

Indexed keywords

BENZALKONIUM CHLORIDE; DNA; DODECYL SULFATE SODIUM; IRRITANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; IRRITANT DERMATITIS; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0034057009     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050032     Document Type: Article

References (30)

1. Basketter DA, Griffiths HA, Wang XM, Wilhelm KP, McFadden JP (1996) Individual ethnic and seasonal variability in irritant susceptibility of skin: implications for a predictive human patch test. Contact Dermatitis 35:208-213
2. Berardesca E, Distante F (1994) The modulation of skin irritation. Contact Dermatitis 31:281-287
3. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, Von Blomberg BME, Kostense PJ, Giphart MJ, Schreuder GMT, Meuwissen SGM, Pena AS (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand J Immunol 43:456-463
4. Cabrera M, Shaw MA, Shaples C, Williams H, Castes M, Conuit J, Blackwell JM (1995) Polymorphisms in tumour necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182:1259-1264
5. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, Jennings R, Mbena E, Mabey DC (1997) Scarring trachoma is associated with polymorphisms in tumour necrosis factor alpha gene promoter and with elevated TNFA in tear fluid. Infect Immunity 65:1003-1006
6. Cumberbatch M, Kimber I (1995) Tumour necrosis factor α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31-35
7. Effendy I, Maibach HI (1995) Surfactants and experimental irritant contact dermatitis. Contact Dermatitis 33:217-225
8. Frosch PJ (1992) Cutaneous irritation. In: Rycroft RJG, Menne T, Frosch PJ, Benezera C (eds) Contact dermatitis. Springer, Berlin Heidelberg New York, pp 28-61
9. Groot AC de (1994) Patch testing, 2nd edn. Elsevier, Amsterdam
10. Groves RW, Allen MH, Ross EL, Barker JNWN, MacDonald DM (1995) Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352
11. Huang SL, Su CH, Chang SC (1997) Tumour necrosis factor alpha gene polymorphisms in chronic bronchitis. Am J Resp Crit Care Med 156:1436-1439
12. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, Gaer L van der, Dams L, Crusius JB, Garcia-Gonzalez A, Van Oosten BW, Polman CH, Pena AS (1997) TNFA promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149-153
13. Hunziker T, Brand CU, Kapp A, Waelti ER, Braathen LR (1992) Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis. Br J Derm 127:254-257
14. Judge MR, Griffiths HA, Basketter DA, White IR, Rycroft RJG, McFadden JP (1996) Variation in response of human skin to irritant challenge. Contact Dermatitis 34:115-117
15. Kimber I, Dearman RJ, Cumberbatch M (1997) Epidermal cytokines and the induction of allergic and non-allergic contact dermatitis. Arch Toxicol 19:229-238
16. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA (1990) Human keratinocytes are a source for tumour necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614
17. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism affects transcription. Mol Immunol 34:391-399
18. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahicu P, Malaise M, De Groote D, Louis R, Belaiche J (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF α-chain gene production in lipopolysaccharide (LPS)-stimulated whole blood culture in healthy humans. Clin Exp Immunol 113:401-406
19. McGuire W, Hill AVS, Allsop CEM, Greenwood BM, Kwiatkowski D (1994) Variation in the TNFA promoter region associated with susceptibility to cerebral malaria. Nature 31:508-511
20. McGuire RS, Mascie-Taylor WCG, Saha B, Hazra SK, Hill AV, Kwiatkowski D (1997) Tumour necrosis factor promoter polymorphisms and susceptibility to lepromatous leprosy. J Infect Dis 176:530-532
21. Muscher B, Schmitt W, Csernok E, Tatsis E, Reil A, Cross WL, Seyfarth M (1997) Polymorphisms in tumour necrosis factor genes in Wegeners granulomatosis. Exp Clin Immunogenet 14:226-233
22. Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumour necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679
23. Rycroft R (1992) Occupational contact dermatitis. In: Rycroft RJG, Menne T, Frosch PJ, Benezera C (eds) Contact dermatitis. Springer, Berlin Heidelberg New York, pp 341-399
24. Seitzer U, Swider C, Stuber F, Suchniki K, Lange A, Richter E, Zabel P, Muller-Quernheim J, Flad HD, Gerdes J (1997) Tumour necrosis factor alpha genetic polymorphisms in sarcoidosis. Cytokine 9:787-790
25. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman O, Petri MA (1997) A promoter polymorphism of tumour necrosis factor alpha associated with systemic lupus erythematosus in African-Asians. Arthritis Rheum 40:2207-2211
26. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coffier B, Salles G (1998) Genetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 10:3574-3581
27. Willis CM, Stephens CJM, Wilkinson JD (1991) Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 96:505-511
28. Wilson AG, Giovine FS di, Blakemore AIF, Duff GW (1992) Single base change in the tumour necrosis factor alpha (TNFA) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353
29. Wilson AG, Vries N, Pociot F de, Giovine FS di, Putte LBA van der, Duff GW (1993) An allelic polymorphism within the human tumour necrosis factor a promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 177:557-560
30. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199